Viscosupplementation with intra-articular hyaluronic acid for treatment of osteoarthritis in the elderly

Current Pharmaceutical Design

Volumn 16, Issue 6, 2010, Pages 631-640

  Abate, M ^a,b   Pulcini, D ^a   Di Iorio, A ^a   Schiavone, C ^a  

^a UNIVERSITY OF CHIETI   (Italy)

^b Department of General and Laparoscopic Surgery University G d' Annunzio ^*  (Italy)

Author keywords

Hyaluronic acid; Intraarticular treatment; Osteoarthritis; Viscosupplementation

Indexed keywords

ANALGESIC AGENT; CORTICOSTEROID; CYCLOOXYGENASE 2 INHIBITOR; HYALURONIC ACID; METHYLPREDNISOLONE; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; STEROID; TRIAMCINOLONE;

AGED; ANKLE OSTEOARTHRITIS; ARTHRALGIA; ARTICLE; BACTERIAL ARTHRITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DISEASE COURSE; DRUG ACTIVITY; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; HAND OSTEOARTHRITIS; HIP OSTEOARTHRITIS; HUMAN; KNEE OSTEOARTHRITIS; META ANALYSIS; MOLECULAR WEIGHT; OSTEOARTHRITIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECOMMENDED DRUG DOSE; SHOULDER ARTHRITIS; SYSTEMATIC REVIEW; TREATMENT INDICATION; TREATMENT OUTCOME; VISCOELASTICITY; AGING; CLINICAL TRIAL (TOPIC); DRUG EFFECTS; ECHOGRAPHY; INTRAARTICULAR DRUG ADMINISTRATION; PATHOLOGY; PROCEDURES; VISCOSUPPLEMENTATION;

AGED; AGING; CLINICAL TRIALS AS TOPIC; HUMANS; HYALURONIC ACID; INJECTIONS, INTRA-ARTICULAR; OSTEOARTHRITIS; TREATMENT OUTCOME; VISCOSUPPLEMENTATION;

EID: 77950283694     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161210790883859     Document Type: Article

References (138)

1. Lawrence RC, Helmick CG, Arnett FC, Deyo RA, Felson DT, Giannini EH, et al. Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum 1998; 41:778-799
2. Hochberg MC, Altman RD, Brandt KD, Clark BM, Dieppe PA, Griffin MR, et al. Guidelines for the medical management of osteoarthritis. Part I. Osteoarthritis of the hip. American College of Rheumatology. Arthritis Rheum 1995; 38:1535-1540
3. Smalley WE, Griffin MR. The risks and costs of upper gastrointestinal disease attributable to NSAIDs. Gastroenterol Clin North Am 1996; 25: 373-396
4. Griffin MR, Ray WA, Schaffner W. Nonsteroidal anti-inflammatory drug use and death from peptic ulcer in elderly persons. Ann Intern Med 1988; 109: 359-363
5. Griffin MR, Piper JM, Daugherty JR, Snowden M, Ray WA. Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons. Ann Intern Med 1991; 114: 257-263
6. Motsko SP, Rascati KL, Busti AJ, Wilson JP, Barner JC, Lawson KA, et al. Temporal relationship between use of NSAIDs, including selective COX-2 inhibitors, and cardiovascular risk. Drug Saf 2006; 29: 621-632
7. Roughead EE, Ramsay E, Pratt N, Gilbert AL. NSAID use in individuals at risk of renal adverse events: an observational study to investigate trends in Australian veterans. Drug Saf 2008; 31: 997-1003.
8. Savage R. Cyclo-oxygenase-2 inhibitors: when should they be used in the elderly? Drugs Aging 2005; 22: 185-200.
9. Page J, Henry D. Consumption of NSAIDs and the development of congestive heart failure in elderly patients: an underrecognized public health problem. Arch Intern Med 2000; 160: 777-784
10. Rashad S, Revell P, Hemingway A, Low F, Rainsford K, Walker F. Effect of non-steroidal anti-inflammatory drugs on the course of osteoarthritis. Lancet 1989; 2: 519-522
11. Sturkenboom MC, Romano F, Simon G, Correa-Leite ML, Villa M, Nicolosi A, et al. The iatrogenic costs of NSAID therapy: a population study. Arthritis Rheum 2002; 47: 132-140
12. Flanagan J, Casale FF, Thomas TL, Desai KB. Intra-articular injection for pain relief in patients awaiting hip replacement. Ann R Coll Surg Engl 1988; 70: 156-157
13. Plant MJ, Borg AA, Dziedzic K, Saklatvala J, Dawes PT. Radiographic patterns and response to cortico - steroid hip injection. Ann Rheum Dis 1997; 56: 476-480
14. Menkes CJ. Intraarticular treatment of osteoarthritis and guidelines to its assessment. J Rheumatol Suppl 1994; 41: 74-76
15. Pyne D, Ioannou Y, Mootoo R, Bhanji A. Intra-articular steroids in knee osteoarthritis: a comparative study of triamcinolone hexacetonide and methylprednisolone acetate. Clin Rheumatol 2004; 23: 116-120
16. Srinivasan A, Amos M, Webley M. The effects of joint washout and steroid injection compared with either joint washout or steroid injection alone in rheumatoid knee effusion. Br J Rheumatol 1995; 34: 771-773
17. Creamer P. Intra-articular cortico-steroid treatment in osteoarthritis. Curr Opin Rheumatol 1999; 11: 417-421
18. Lazarevic MB, Skosey JL, Djordjevic-Denic G, Swedler WI, Zgradic I, Myones BL. Reduction of cortisol levels after single intra-articular and intramuscular steroid injection. Am J Med 1995; 99: 370-373
19. Mader R, Lavi I, Luboshitzky R. Evaluation of the pituitary-adrenal axis function following single intraarticular injection of methylprednisolone. Arthritis Rheum 2005; 52: 924-928
20. Weitoft T, Larsson A, Saxne T, Ronnblom L. Changes of cartilage and bone markers after intra-articular glucocorticoid treatment with and without postinjection rest in patients with rheumatoid arthritis. Ann Rheum Dis 2005; 64: 1750-1753
21. Weitoft T, Larsson A, Ronnblom L. Serum levels of sex steroid hormones and matrix metalloproteinases after intra-articular glucocorticoid treatment in female patients with rheumatoid arthritis. Ann Rheum Dis 2008; 67: 422-424
22. Yamamoto T, Schneider R, Iwamoto Y, Bullough PG. Rapid destruction of the femoral head after a single intraarticular injection of cortico-steroid into the hip joint. J Rheumatol 2006; 33: 1701-1704
23. Rogojan C, Hetland ML. Depigmentation - a rare side effect to intra-articular glucocorticoid treatment. Clin Rheumatol 2004; 23: 373-375
24. Zaman FM, Wong M, Slipman CW, Ellen MI. Dysphonia associated with shoulder steroid injection. Am J Phys Med Rehabil 2005; 84: 307-309
25. O'Regan M, Martini I, Crescenzi F, De Luca C, Lansing M. Molecular mechanisms and genetics of hyaluronan biosynthesis. Int J Biol Macromol 1994; 16: 283-286
26. van den Bekerom MP, Lamme B, Sermon A, Mulier M. What is the evidence for viscosupplementation in the treatment of patients with hip osteoarthritis? Systematic review of the literature. Arch Orthop Trauma Surg 2008; 128: 815-823
27. van den Bekerom MP, Mylle G, Rys B, Mulier M. Viscosupplementation in symptomatic severe hip osteoarthritis: a review of the literature and report on 60 patients. Acta Orthop Belg 2006; 72: 560-568
28. Kikuchi T, Yamada H, Fujikawa K. Effects of high molecular weight hyaluronan on the distribution and movement of proteoglycan around chondrocytes cultured in alginate beads. Osteoarthr Cartil 2001; 9: 351-356
29. Vad VB, Sakalkale D, Sculco TP, Wickiewicz TL. Role of hylan GF 20 in treatment of osteoarthritis of the hip joint. Arch Phys Med Rehabil 2003; 84: 1224-1226
30. Han F, Ishiguro N, Ito T, Sakai T, Iwata H. Effects of sodium hyaluronate on experimental osteoarthritis in rabbit knee joints. Nagoya J Med Sci 1999; 62: 115-126
31. Takahashi K, Goomer RS, Harwood F, Kubo T, Hirasawa Y, Amiel D. The effects of hyaluronan on matrix metalloproteinase-3 (MMP-3), interleukin-1beta (IL-1beta), and tissue inhibitor of metalloproteinase-1 (TIMP-1) gene expression during the development of osteoarthritis. Osteoarthr Cartil 1999; 7: 182-190
32. Goto H, Onodera T, Hirano H, Shimamura T. Hyaluronic acid suppresses the reduction of alpha2(VI) collagen gene expression caused by interleukin-1beta in cultured rabbit articular chondrocytes. Tohoku J Exp Med 1999; 187: 1-13.
33. Homandberg GA, Hui F, Wen C, Kuettner KE, Williams JM. Hyaluronic acid suppresses fibronectin fragment mediated cartilage chondrolysis: I. In vitro. Osteoarthr Cartil 1997; 5: 309-319
34. Williams JM, Plaza V, Hui F, Wen C, Kuettner KE, Homandberg GA. Hyaluronic acid suppresses fibronectin fragment mediated cartilage chondrolysis: II. In vivo. Osteoarthr Cartil 1997; 5: 235-240
35. Bagga H, Burkhardt D, Sambrook P, March L. Longterm effects of intraarticular hyaluronan on synovial fluid in osteoarthritis of the knee. J Rheumatol 2006; 33: 946-950
36. Ghosh P, Guidolin D. Potential mechanism of action of intra-articular hyaluronan therapy in osteoarthritis: are the effects molecular weight dependent? Semin Arthritis Rheum 2002; 32: 10-37.
37. Aihara S, Murakami N, Ishii R, Kariya K, Azuma Y, Hamada K, et al. Effects of sodium hyaluronate on the nociceptive response of rats with experimentally induced arthritis. Nippon Yakurigaku Zasshi 1992; 100: 359-365
38. Forrester JV, Balazs EA. Inhibition of phagocytosis by high molecular weight hyaluronate. Immunology 1980; 40: 435-446
39. Berg P, Olsson U. Intra-articular injection of non-animal stabilised hyaluronic acid (NASHA) for osteoarthritis of the hip: a pilot study. Clin Exp Rheumatol 2004; 22: 300-306
40. Larsen NE, Leshchiner EA, Parent EG, Hendrikson-Aho J, Balazs EA, Hilal SK. Hylan gel composition for percutaneous embolization. J Biomed Mater Res 1991; 25: 699-710.
41. Weiss C, Band P. Musculoskeletal applications of hyaluronan and hylan. Potential uses in the foot and ankle. Clin Podiatr Med Surg 1995; 12: 497-517.
42. Brzusek D, Petron D. Treating knee osteoarthritis with intra-articular hyaluronans. Curr Med Res Opin 2008; 24: 3307-3322
43. Kellgren JH, Lawrence JS. Radiological assessment of osteo-arthrosis. Ann Rheum Dis 1957; 16: 494-502.
44. Kemper F, Gebhardt U, Meng T, Murray C. Tolerability and short-term effectiveness of hylan G-F 20 in 4253 patients with osteoarthritis of the knee in clinical practice. Curr Med Res Opin 2005; 21: 1261-1269
45. Waddell DD. Viscosupplementation with hyaluronans for osteoarthritis of the knee: clinical efficacy and economic implications. Drugs Aging 2007; 24: 629-642
46. Migliore A, Tormenta S, Martin Martin LS, Valente C, Massafra U, Latini A, et al. Safety profile of 185 ultrasound-guided intra-articular injections for treatment of rheumatic diseases of the hip. Reumatismo 2004; 56:104-109
47. Pourbagher MA, Ozalay M, Pourbagher A. Accuracy and outcome of sonographically guided intra-articular sodium hyaluronate injections in patients with osteoarthritis of the hip. J Ultrasound Med 2005; 24: 1391-1395
48. Qvistgaard E, Kristoffersen H, Terslev L, Danneskiold-Samsoe B, Torp-Pedersen S, Bliddal H. Guidance by ultrasound of intra-articular injections in the knee and hip joints. Osteoarthr Cartil 2001; 9: 512-517
49. Hunter DJ, Lo GH. The management of osteoarthritis: an overview and call to appropriate conservative treatment. Rheum Dis Clin North Am 2008; 34: 689-712.
50. National Collaborating Centre for Chronic Conditions at the Royal College of Physicians. Osteoarthritis: National clinical guideline for care and management in adults. Royal College of Physicians, 2008.
51. Bellamy N. Hyaluronic acid and knee osteoarthritis. J Fam Pract 2006; 55: 967-968
52. Bellamy N, Campbell J, Robinson V, Gee T, Bourne R, Wells G. Intraarticular cortico-steroid for treatment of osteoarthritis of the knee. Cochrane Database Syst Rev 2006; CD005328.
53. Bellamy N. Hyaluronic acid and knee osteoarthritis. J Fam Pract 2006; 55: 967-968
54. Petrella RJ, Petrella M. A prospective, randomized, double-blind, placebo controlled study to evaluate the efficacy of intraarticular hyaluronic acid for osteoarthritis of the knee. J Rheumatol 2006; 33: 951-956
55. Lo GH, LaValley M, McAlindon T, Felson DT. Intra-articular hyaluronic acid in treatment of knee osteoarthritis: a meta-analysis. JAMA 2003; 290: 3115-3121
56. Lohmander LS, Dalen N, Englund G, Hamalainen M, Jensen EM, Karlsson K, et al. Intra-articular hyaluronan injections in the treatment of osteoarthritis of the knee: a randomised, double blind, placebo controlled multicentre trial. Hyaluronan Multicentre Trial Group. Ann Rheum Dis 1996; 55: 424-431
57. Puhl W, Bernau A, Greiling H, Kopcke W, Pforringer W, Steck KJ, et al. Intra-articular sodium hyaluronate in osteoarthritis of the knee: a multicenter, double-blind study. Osteoarthr Cartil 1993; 1: 233-241
58. Raynauld JP, Torrance GW, Band PA, Goldsmith CH, Tugwell P, Walker V, et al. A prospective, randomized, pragmatic, health outcomes trial evaluating the incorporation of hylan G-F 20 into the treatment paradigm for patients with knee osteoarthritis (Part 1 of 2): clinical results. Osteoarthr Cartil 2002; 10: 506-517
59. Sun SF, Hsu CW, Hwang CW, Hsu PT, Wang JL, Tsai SL, et al. Hyaluronate improves pain, physical function and balance in the geriatric osteoarthritic knee: a 6-month follow-up study using clinical tests. Osteoarthr Cartil 2006; 14: 696-701.
60. Conrozier T, Jerosch J, Beks P, Kemper F, Euller-Ziegler L, Bailleul F, et al. Prospective, multi-centre, randomised evaluation of the safety and efficacy of five dosing regimens of viscosupplementation with hylan G-F 20 in patients with symptomatic tibio-femoral osteoarthritis: a pilot study. Arch Orthop Trauma Surg 2009; 129: 417-423
61. Rossini M, Viapiana O, Ramonda R, Bianchi G, Olivieri I, Lapadula G, et al. Intra-articular clodronate for the treatment of knee osteoarthritis: dose ranging study vs hyaluronic acid. Rheumatology (Oxford) 2009; 48: 773-778
62. Aggarwal A, Sempowski IP. Hyaluronic acid injections for knee osteoarthritis. Systematic review of the literature. Can Fam Phys 2004; 50: 249-256
63. Belo JN, Berger MY, Reijman M, Koes BW, Bierma-Zeinstra SM. Prognostic factors of progression of osteoarthritis of the knee: a systematic review of observational studies. Arthritis Rheum 2007; 57: 13-26.
64. Divine JG, Zazulak BT, Hewett TE. Viscosupplementation for knee osteoarthritis: a systematic review. Clin Orthop Relat Res 2007; 455: 113-122
65. Adams ME, Atkinson MH, Lussier AJ, Schulz JI, Siminovitch KA, Wade JP, et al. The role of viscosupplementation with hylan G-F 20 (Synvisc) in the treatment of osteoarthritis of the knee: a Canadian multicenter trial comparing hylan G-F 20 alone, hylan G-F 20 with non-steroidal anti-inflammatory drugs (NSAIDs) and NSAIDs alone. Osteoarthr Cartil 1995; 3: 213-225
66. Campbell J, Bellamy N, Gee T. Differences between systematic reviews/meta-analyses of hyaluronic acid/hyaluronan/hylan in osteoarthritis of the knee. Osteoarthr Cartil 2007; 15: 1424-1436
67. Dagenais S. Intra-articular hyaluronic acid (viscosupplementation) for knee osteoarthritis. Issues Emerg Health Technol 2006; 94: 1-4.
68. Hamburger MI, Lakhanpal S, Mooar PA, Oster D. Intra-articular hyaluronans: a review of product-specific safety profiles. Semin Arthritis Rheum 2003; 32: 296-309.
69. Chua SD Jr, Messier SP, Legault C, Lenz ME, Thonar EJ, Loeser RF. Effect of an exercise and dietary intervention on serum biomarkers in overweight and obese adults with osteoarthritis of the knee. Osteoarthr Cartil 2008; 16: 1047-1053
70. Leopold SS, Battista V, Oliverio JA. Safety and efficacy of intraarticular hip injection using anatomic landmarks. Clin Orthop Relat Res 2001; 391: 192-197
71. Conrozier T, Bertin P, Mathieu P, Charlot J, Bailleul F, Treves R, et al. Intra-articular injections of hylan G-F 20 in patients with symptomatic hip osteoarthritis: an open-label, multicentre, pilot study. Clin Exp Rheumatol 2003; 21: 605-610
72. Migliore A, Martin LS, Alimonti A, Valente C, Tormenta S. Efficacy and safety of viscosupplementation by ultrasound-guided intra-articular injection in osteoarthritis of the hip. Osteoarthr Cartil 2003; 11: 305-306
73. Caglar-Yagci H, Unsal S, Yagci I, Dulgeroglu D, Ozel S. Safety and efficacy of ultrasound-guided intra-articular hylan G-F 20 injection in osteoarthritis of the hip: a pilot study. Rheumatol Int 2005; 25: 341-344
74. Abate M, Pelotti P, De Amicis D, Di Iorio A, Galletti S, Salini V. Viscosupplementation with hyaluronic acid in hip osteoarthritis (a review). Ups J Med Sci 2008; 113: 261-277
75. Brocq O, Tran G, Breuil V, Grisot C, Flory P, Euller-Ziegler L. Hip osteoarthritis: short-term efficacy and safety of viscosupplementation by hylan G-F 20. An open-label study in 22 patients. Joint Bone Spine 2002; 69: 388-391
76. Migliore A, Tormenta S, Valente C, Massafra U, Martin Martin LS, Carmenini E, et al. Intra-articular treatment with Hylan G-F 20 under ultrasound guidance in hip osteoarthritis. Clinical results after 12 months follow-up. Reumatismo 2005; 57: 36-43.
77. Migliore A, Tormenta S, Martin LS, Valente C, Massafra U, Granata M, et al. Open pilot study of ultrasound-guided intra-articular injection of hylan G-F 20 (Synvisc) in the treatment of symptomatic hip osteoarthritis. Clin Rheumatol 2005; 24: 285-289
78. Migliore A, Tormenta S, Massafra U, Carloni E, Padalino C, Iannessi F, et al. Repeated ultrasound-guided intra-articular injections of 40 mg of Hyalgan may be useful in symptomatic relief of hip osteoarthritis. Osteoarthr Cartil 2005; 13: 1126-1127
79. Migliore A, Tormenta S, Martin Martin LS, Iannessi F, Massafra U, Carloni E, et al. The symptomatic effects of intra-articular administration of hylan G-F 20 on osteoarthritis of the hip: clinical data of 6 months follow-up. Clin Rheumatol 2006; 25: 389-393
80. Migliore A, Tormenta S, Massafra U, Martin Martin LS, Carloni E, Padalino C, et al. 18-month observational study on efficacy of intraarticular hyaluronic acid (Hylan G-F 20) injections under ultrasound guidance in hip osteoarthritis. Reumatismo 2006; 58: 39-49.
81. van den Bekerom MP, Rys B, Mulier M. Viscosupplementation in the hip: evaluation of hyaluronic acid formulations. Arch Orthop Trauma Surg 2008; 128: 275-280
82. Fletcher B, Sackett D. Canadian task force on the periodic health esamination: the Periodic Health Examination. CMAJ 1979; 121: 1193-1254
83. Tikiz C, Unlu Z, Sener A, Efe M, Tuzun C. Comparison of the efficacy of lower and higher molecular weight viscosupplementation in the treatment of hip osteoarthritis. Clin Rheumatol 2005; 24: 244-250
84. Qvistgaard E, Christensen R, Torp-Pedersen S, Bliddal H. Intra-articular treatment of hip osteoarthritis: a randomized trial of hyaluronic acid, cortico-steroid, and isotonic saline. Osteoarthr Cartil 2006; 14: 163-170
85. Felson DT, Anderson JJ. Hyaluronate sodium injections for osteoarthritis: hope, hype, and hard truths. Arch Intern Med 2002; 162: 245-247
86. Kirwan JR, Rankin E. Intra-articular therapy in osteoarthritis. Baillieres Clin Rheumatol 1997; 11: 769-794
87. Richette P, Ravaud P, Conrozier T, Euller-Ziegler L, Mazieres B, Maugars Y, et al. Effect of hyaluronic acid in symptomatic hip osteoarthritis: a multicenter, randomized, placebo-controlled trial. Arthritis Rheum 2009; 60: 824-830
88. Sun SF, Chou YJ, Hsu CW, Hwang CW, Hsu PT, Wang JL, et al. Efficacy of intra-articular hyaluronic acid in patients with osteoarthritis of the ankle: a prospective study. Osteoarthr Cartil 2006; 14: 867-874
89. Witteveen AG, Giannini S, Guido G, Jerosch J, Lohrer H, Vannini F, et al. A prospective multi-centre, open study of the safety and efficacy of hylan G-F 20 (Synvisc) in patients with symptomatic ankle (talo-crural) osteoarthritis. Foot Ankle Surg 2008; 14: 145-152
90. Karatosun V, Unver B, Ozden A, Ozay Z, Gunal I. Intra-articular hyaluronic acid compared to exercise therapy in osteoarthritis of the ankle. A prospective randomized trial with long-term follow-up. Clin Exp Rheumatol 2008; 26: 288-294
91. Luciani D, Cadossi M, Tesei F, Chiarello E, Giannini S. Viscosupplementation for grade II osteoarthritis of the ankle: a prospective study at 18 months' follow-up. Chir Organi Mov 2008; 92: 155-160
92. Carpenter B, Motley T. The role of viscosupplementation in the ankle using hylan G-F 20. J Foot Ankle Surg 2008; 47: 377-384
93. Cohen MM, Altman RD, Hollstrom R, Hollstrom C, Sun C, Gipson B. Safety and efficacy of intra-articular sodium hyaluronate (Hyalgan) in a randomized, double-blind study for osteoarthritis of the ankle. Foot Ankle Int 2008; 29: 657-663
94. Salk RS, Chang TJ, D'Costa WF, Soomekh DJ, Grogan KA. Sodium hyaluronate in the treatment of osteoarthritis of the ankle: a controlled, randomized, double-blind pilot study. J Bone Joint Surg Am 2006; 88: 295-302.
95. Mei-Dan O, Maoz G, Swartzon M, Onel E, Kish B, Nyska M, et al. Treatment of osteochondritis dissecans of the ankle with hyaluronic acid injections: a prospective study. Foot Ankle Int 2008; 29: 1171-1178
96. Gregory AJ. Periarticular hyaluronic Acid as an adjunct to standard care for acute ankle sprain. Clin J Sport Med 2008; 18: 474-475
97. Petrella RJ, Petrella MJ, Cogliano A. Periarticular hyaluronic acid in acute ankle sprain. Clin J Sport Med 2007; 17: 251-257
98. Wang CW, Gao LH, Jin XY, Chen PB, Zhang GM. Clinical study of sodium hyaluronate in supplementary treatment of comminuted fracture of ankle. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 2002; 16: 21-22
99. Zwar RB, Read JW, Noakes JB. Sonographically guided glenohumeral joint injection. AJR Am J Roentgenol 2004; 183: 48-50.
100. Blaine T, Moskowitz R, Udell J, Skyhar M, Levin R, Friedlander J, et al. Treatment of persistent shoulder pain with sodium hyaluronate: a randomized, controlled trial. A multicenter study. J Bone Joint Surg Am 2008; 90: 970-979
101. Leardini G, Perbellini A, Franceschini M, Mattara L. Intra-articular injections of hyaluronic acid in the treatment of painful shoulder. Clin Ther 1988; 10: 521-526
102. Silverstein E, Leger R, Shea KP. The use of intra-articular hylan GF 20 in the treatment of symptomatic osteoarthritis of the shoulder: a preliminary study. Am J Sports Med 2007; 35: 979-985
103. Itokazu M, Matsunaga T. Clinical evaluation of high-molecular-weight sodium hyaluronate for the treatment of patients with periarthritis of the shoulder. Clin Ther 1995; 17: 946-955
104. Calis M, Demir H, Ulker S, Kirnap M, Duygulu F, Calis HT. Is intraarticular sodium hyaluronate injection an alternative treatment in patients with adhesive capsulitis? Rheumatol Int 2006; 26: 536-540
105. Fernandez-Palazzi F, Viso R, Boadas A, Ruiz-Saez A, Caviglia H, De Bosch NB. Intra-articular hyaluronic acid in the treatment of haemophilic chronic arthropathy. Haemophilia 2002; 8: 375-381
106. Rovetta G, Monteforte P. Intraarticular injection of sodium hyaluronate plus steroid versus steroid in adhesive capsulitis of the shoulder. Int J Tissue React 1998; 20: 125-130
107. Tamai K, Mashitori H, Ohno W, Hamada J, Sakai H, Saotome K. Synovial response to intraarticular injections of hyaluronate in frozen shoulder: a quantitative assessment with dynamic magnetic resonance imaging. J Orthop Sci 2004; 9: 230-234
108. Karalezli N, Ogun TC, Kartal S, Saracgil SN, Yel M, Tuncay I. The pain associated with intraarticular hyaluronic acid injections for trapeziometacarpal osteoarthritis. Clin Rheumatol 2007; 26: 569-571
109. Heyworth BE, Lee JH, Kim PD, Lipton CB, Strauch RJ, Rosenwasser MP. Hylan versus cortico-steroid versus placebo for treatment of basal joint arthritis: a prospective, randomized, double-blinded clinical trial. J Hand Surg Am 2008; 33: 40-48
110. Salini V, De Amicis D, Abate M, Natale MA, Di Iorio A. Ultrasound-guided hyaluronic acid injection in carpometacarpal osteoarthritis: short-term results. Int J Immunopathol Pharmacol 2009; 22: 455-460
111. Coaccioli S, Pinoca F, Puxeddu A. Short term efficacy of intra-articular injection of hyaluronic acid in osteoarthritis of the first carpometacarpal joint in a preliminary open pilot study. Clin Ter 2006; 157: 321-325
112. Roux C, Fontas E, Breuil V, Brocq O, Albert C, Euller-Ziegler L. Injection of intra-articular sodium hyaluronidate (Sinovial) into the carpometacarpal joint of the thumb (CMC1) in osteoarthritis. A prospective evaluation of efficacy. Joint Bone Spine 2007; 74: 368-372
113. Schumacher HR, Meador R, Sieck M, Mohammed Y. Pilot Investigation of hyaluronate injections for first Metacarpal-Carpal (MC-C) osteoarthritis. J Clin Rheumatol 2004; 10: 59-62.
114. Stahl S, Karsh-Zafrir I, Ratzon N, Rosenberg N. Comparison of intraarticular injection of depot cortico-steroid and hyaluronic acid for treatment of degenerative trapeziometacarpal joints. J Clin Rheumatol 2005; 11: 299-302.
115. Fuchs S, Monikes R, Wohlmeiner A, Heyse T. Intra-articular hyaluronic acid compared with corticoid injections for the treatment of rhizarthrosis. Osteoarthr Cartil 2006; 14: 82-88
116. Meenagh GK, Patton J, Kynes C, Wright GD. A randomised controlled trial of intra-articular cortico-steroid injection of the carpometacarpal joint of the thumb in osteoarthritis. Ann Rheum Dis 2004; 63: 1260-1263
117. Maheu E, Dreiser RL, Lequesne M. Methodology of clinical trials in hand osteoarthritis. Issues and proposals. Rev Rhum Engl Ed 1995; 62: 55S-62S.
118. Pons M, Alvarez F, Solana J, Viladot R, Varela L. Sodium hyaluronate in the treatment of hallux rigidus. A single-blind, randomized study. Foot Ankle Int 2007; 28: 38-42.
119. Calvillo O, Skaribas I, Turnipseed J. Anatomy and pathophysiology of the sacroiliac joint. Curr Rev Pain 2000; 4: 356-361
120. Srejic U, Calvillo O, Kabakibou K. Viscosupplementation: a new concept in the treatment of sacroiliac joint syndrome: a preliminary report of four cases. Reg Anesth Pain Med 1999; 24: 84-88
121. Wang W, Li P, Zhang YL, Yang Y, Wang FL, Zhang Y. The clinical effects of percutaneous lumbar discectomy combined with sodium hyaluronate in the treatment of lumbar intervertebral disc herniation. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 2002; 16: 23-25
122. Hanson EC. Sodium hyaluronate - application in a community practice. Am J Orthop 1999; 28: 11-12
123. van Brakel RW, Eygendaal D. Intra-articular injection of hyaluronic acid is not effective for the treatment of post-traumatic osteoarthritis of the elbow. Arthroscopy 2006; 22: 1199-1203
124. Fuchs S, Erbe T, Fischer HL, Tibesku CO. Intraarticular hyaluronic acid versus glucocorticoid injections for nonradicular pain in the lumbar spine. J Vasc Interv Radiol 2005; 16: 1493-1498
125. Cleary M, Keating C, Poynton AR. Viscosupplementation in lumbar facet joint arthropathy: a pilot study. J Spinal Disord Tech 2008; 21: 29-32.
126. Bertolami CN, Gay T, Clark GT, Rendell J, Shetty V, Liu C, et al. Use of sodium hyaluronate in treating temporomandibular joint disorders: a randomized, double-blind, placebo-controlled clinical trial. J Oral Maxillofac Surg 1993; 51: 232-242
127. Bjornland T, Gjaerum AA, Moystad A. Osteoarthritis of the temporomandibular joint: an evaluation of the effects and complications of cortico-steroid injection compared with injection with sodium hyaluronate. J Oral Rehabil 2007; 34: 583-589
128. Guarda-Nardini L, Masiero S, Marioni G. Conservative treatment of temporomandibular joint osteoarthrosis: intra-articular injection of sodium hyaluronate. J Oral Rehabil 2005; 32: 729-734
129. Guarda-Nardini L, Stifano M, Brombin C, Salmaso L, Manfredini D. A one-year case series of arthrocentesis with hyaluronic acid injections for temporomandibular joint osteoarthritis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007; 103: e14-e22.
130. Guarda NL, Oliviero F, Ramonda R, Ferronato G. Influence of intra-articular injections of sodium hyaluronate on clinical features and synovial fluid nitric oxide levels of temporomandibular osteoarthritis. Reumatismo 2004; 56: 272-277
131. Chazerain P, Rolland D, Cordonnier C, Ziza JM. Septic hip arthritis after multiple injections into the joint of hyaluronate and glucocorticoid. Rev Rhum Engl Ed 1999; 66: 436.
132. Bellamy N, Campbell J, Robinson V, Gee T, Bourne R, Wells G. Viscosupplementation for the treatment of osteoarthritis of the knee. Cochrane Database of Systematic Revues, editor. 2. 2006.
133. Gaston MS, Tiemessen CH, Philips JE. Intra-articular hip viscosupplementation with synthetic hyaluronic acid for osteoarthritis: efficacy, safety and relation to pre-injection radiographs. Arch Orthop Trauma Surg 2007; 127: 899-903.
134. Gaffney K, Ledingham J, Perry JD. Intra-articular triamcinolone hexacetonide in knee osteoarthritis: factors influencing the clinical response. Ann Rheum Dis 1995; 54: 379-381
135. Jones A, Regan M, Ledingham J, Pattrick M, Manhire A, Doherty M. Importance of placement of intra-articular steroid injections. BMJ 1993; 307: 1329-1330
136. Egsmose C, Lund B, Bach AR. Hip joint distension in osteoarthrosis. A triple-blind controlled study comparing the effect of intra-articular indoprofen with placebo. Scand J Rheumatol 1984; 13: 238-242
137. Kirwan J. Is there a place for intra-articular hyaluronate in osteoarthritis of the knee? Knee 2001; 8: 93-101.
138. Ravaud P, Moulinier L, Giraudeau B, Ayral X, Guerin C, Noel E, et al. Effects of joint lavage and steroid injection in patients with osteoarthritis of the knee: results of a multicenter, randomized, controlled trial. Arthritis Rheum 1999; 42: 475-482